# QuidelOrtho Corporation  Share Price Target ‘$95.14’, now 40.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/quidelortho-corporation-share-price-target-95.14-now-40.7-upside-potential/4121142062
- Published: 2024-02-09T13:38:20+00:00
- Author: Charlotte Edwards

**QuidelOrtho Corporation** with ticker code (QDEL) have now 7 market analysts covering
the stock. The analyst consensus now points to a rating of ‘buy’. The target price
High/Low ranges between $158.00 and $66.00 calculating the average target share 
price we see $95.14. (at the time of writing). Now with the previous closing price
of $67.64 this is indicating there is a potential upside of 40.7%. There is a 50
day moving average of $70.69 and the 200 moving average now moves to $76.37. The
total market capitalization for the company now stands at 4.48B. The stock price
for the company is currently $67.02 USD

 The potential market cap would be $6,298,860,242 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $46.80 and
a 2.21% return on assets.

QuidelOrtho Corporation is a vitro diagnostics company. The Company is engaged in
the development and manufacturing of advanced technologies in diagnostic testing.
Its capabilities include immunoassay and molecular testing, clinical chemistry and
transfusion medicine. The Company’s business units include Labs, Molecular Diagnostics,
Point of Care, and Transfusion Medicine. Its Labs business unit includes Virology,
Specialty Products, Specialty Products, Immunodiagnostics, VITROS Platform, XT Platform,
VITROS XT Platform, and VITROS Automation Solutions. Its Molecular Diagnostics business
includes Lyra, Solana, and Savanna. It provides diagnostic testing solutions under
various brand names, including AdenoPlus, BIOVUE, D, ELVIRA, ELVIS, FastPoint, FreshCells,
InflammaDry, Lyra, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Vision, Quidel,
QuickVue, QuickVue+, QVue, ReadyCells, Savanna, Sofia, Solana, Thyretain, Triage,
Virena, and Vitros.

Share on: